Covered recipient · General Payments record
KATHRYN G MASSENGILL
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,278.93
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $318.97 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $74.42 | 4 |
| MAYNE PHARMA COMMERCIAL LLC | $49.95 | 2 |
| PFIZER INC. | $49.12 | 3 |
| Aspira Women's Health Inc | $43.90 | 2 |
| Inari Medical, Inc. | $29.57 | 1 |
| Sage Therapeutics, Inc. | $24.45 | 1 |
| Organon LLC | $17.51 | 1 |
| Exeltis, USA Inc. | $15.30 | 1 |
| Amgen Inc. | $14.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.75 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117320626 | CMS |
| Aspira Women's Health Inc | $26.04 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126781682 | CMS |
| Aspira Women's Health Inc | $17.86 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126781684 | CMS |
| Astellas Pharma US Inc | $18.85 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139489920 | CMS |
| Astellas Pharma US Inc | $24.38 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139494970 | CMS |
| Astellas Pharma US Inc | $15.04 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139470534 | CMS |
| Astellas Pharma US Inc | $16.15 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139534774 | CMS |
| Exeltis, USA Inc. | $15.30 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150015815 | CMS |
| Inari Medical, Inc. | $29.57 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140187406 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $29.16 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154675785 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $20.79 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154675783 | CMS |
| Organon Llc | $17.51 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136264320 | CMS |
| PFIZER INC. | $14.36 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131307393 | CMS |
| PFIZER INC. | $16.65 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131998229 | CMS |
| PFIZER INC. | $18.11 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131640012 | CMS |
| Sage Therapeutics, Inc. | $24.45 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120401114 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.